ติดตาม
Jeong Pil Han
Jeong Pil Han
ยืนยันอีเมลแล้วที่ snu.ac.kr
ชื่อ
อ้างโดย
อ้างโดย
ปี
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
JP Han, MJ Kim, BS Choi, JH Lee, GS Lee, M Jeong, Y Lee, EA Kim, ...
Science advances 8 (3), eabj6901, 2022
1372022
In vivo genome editing for hemophilia B therapy by the combination of rebalancing and therapeutic gene knockin using a viral and non-viral vector
JH Lee, JP Han, DW Song, GS Lee, BS Choi, MJ Kim, Y Lee, S Kim, ...
Molecular Therapy-Nucleic Acids 32, 161-172, 2023
192023
In vivo multiplex gene targeting with Streptococcus pyogens and Campylobacter jejuni Cas9 for pancreatic cancer modeling in wild-type animal
YJ Chang, J Bae, Y Zhao, G Lee, J Han, YH Lee, OJ Koo, S Seo, YK Choi, ...
Journal of Veterinary Science 21 (2), e26, 2020
172020
Genome editing-mediated knock-in of therapeutic genes ameliorates the disease phenotype in a model of hemophilia
JH Lee, HK Oh, BS Choi, HH Lee, KJ Lee, UG Kim, J Lee, H Lee, GS Lee, ...
Molecular Therapy-Nucleic Acids 29, 551-562, 2022
112022
High homology-directed repair using mitosis phase and nucleus localizing signal
JP Han, YJ Chang, DW Song, BS Choi, OJ Koo, SY Yi, TS Park, SC Yeom
International journal of molecular sciences 21 (11), 3747, 2020
112020
In vivo genome editing using 244-cis LNPs and low-dose AAV achieves therapeutic threshold in hemophilia A mice
JP Han, Y Lee, JH Lee, HY Chung, GS Lee, YR Nam, M Choi, KS Moon, ...
Molecular Therapy Nucleic Acids 34, 2023
82023
Positive correlation between nNOS and stress-activated bowel motility is confirmed by in vivo HiBiT system
JP Han, JH Lee, GS Lee, OJ Koo, SC Yeom
Cells 10 (5), 1028, 2021
82021
Morc2a p.S87L mutant mice develop peripheral and central neuropathies associated with neuronal DNA damage and apoptosis
GS Lee, G Kwak, JH Bae, JP Han, SH Nam, JH Lee, S Song, GD Kim, ...
Disease Models & Mechanisms 14 (10), dmm049123, 2021
72021
Novel severe hemophilia a mouse model with factor VIII intron 22 inversion
JP Han, DW Song, JH Lee, GS Lee, SC Yeom
Biology 10 (8), 704, 2021
62021
In vivo LNP-CRISPR approaches for the treatment of hemophilia
JH Lee, JP Han
Molecular Diagnosis & Therapy 28 (3), 239-248, 2024
52024
The position of the target site for engineered nucleases improves the aberrant mRNA clearance in in vivo genome editing
JH Lee, S Yu, TW Nam, J Roh, Y Jin, JP Han, JY Cha, YK Kim, SC Yeom, ...
Scientific reports 10 (1), 4173, 2020
32020
Morc2a variants cause hydroxyl radical-mediated neuropathy and are rescued by restoring GHKL ATPase
HY Chung, GS Lee, SH Nam, JH Lee, JP Han, S Song, GD Kim, C Jung, ...
Brain 147 (6), 2114-2127, 2024
22024
Polyphenol-Enabled 2D Nanopatch for Enhanced Nasal Mucoadhesion and Immune Activation
JP Han, YR Nam, HY Chung, H Lee, SC Yeom
Nano Letters 24 (33), 10380-10387, 2024
12024
Comparison in vivo knock-in strategy using dual adeno associated virus
JH Lee, DW Song, SJ Ahn, JP Han, GS Lee, SJ Kim, SC Yeom
한국실험동물학회 학술발표대회 논문집, 208-208, 2021
2021
Mitosis stage is optimal timing for CRISPR ribonucleoprotein mediated single strand template repair
JP Han, SC Yeom
한국실험동물학회 학술발표대회 논문집, 139-139, 2019
2019
ระบบไม่สามารถดำเนินการได้ในขณะนี้ โปรดลองใหม่อีกครั้งในภายหลัง
บทความ 1–15